Benlalam H - Search Results

1

A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion.

Linard B, Bézieau S, Benlalam H, Labarrière N, Guilloux Y, Diez E, Jotereau F. Linard B, et al. Among authors: benlalam h. J Immunol. 2002 May 1;168(9):4802-8. doi: 10.4049/jimmunol.168.9.4802. J Immunol. 2002. PMID: 11971032

2

Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes.

Benlalam H, Linard B, Guilloux Y, Moreau-Aubry A, Derré L, Diez E, Dreno B, Jotereau F, Labarrière N. Benlalam H, et al. J Immunol. 2003 Dec 1;171(11):6283-9. doi: 10.4049/jimmunol.171.11.6283. J Immunol. 2003. PMID: 14634146

3

Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy.

Benlalam H, Labarrière N, Linard B, Derré L, Diez E, Pandolfino MC, Bonneville M, Jotereau F. Benlalam H, et al. Eur J Immunol. 2001 Jul;31(7):2007-15. doi: 10.1002/1521-4141(200107)31:7<2007::aid-immu2007>3.0.co;2-s. Eur J Immunol. 2001. PMID: 11449353 Free article.

4

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.

Benlalam H, Vignard V, Khammari A, Bonnin A, Godet Y, Pandolfino MC, Jotereau F, Dreno B, Labarrière N. Benlalam H, et al. Cancer Immunol Immunother. 2007 Apr;56(4):515-26. doi: 10.1007/s00262-006-0204-0. Epub 2006 Jul 28. Cancer Immunol Immunother. 2007. PMID: 16874485 Free PMC article. Clinical Trial.

5

Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules.

Allard M, Oger R, Benlalam H, Florenceau L, Echasserieau K, Bernardeau K, Labarrière N, Lang F, Gervois N. Allard M, et al. Among authors: benlalam h. J Immunol. 2014 Jun 1;192(11):5090-7. doi: 10.4049/jimmunol.1303226. Epub 2014 Apr 21. J Immunol. 2014. PMID: 24752447 Free article.

6

IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cells.

Parrot T, Allard M, Oger R, Benlalam H, Raingeard de la Blétière D, Coutolleau A, Preisser L, Desfrançois J, Khammari A, Dréno B, Labarrière N, Delneste Y, Guardiola P, Gervois N. Parrot T, et al. Among authors: benlalam h. Eur J Immunol. 2016 Jul;46(7):1770-82. doi: 10.1002/eji.201546061. Epub 2016 May 6. Eur J Immunol. 2016. PMID: 27094152 Free article.

7

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

Samimi M, Benlalam H, Aumond P, Gaboriaud P, Fradin D, Kervarrec T, Florenceau L, Vignard V, Blom A, Touzé A, Gervois N, Labarriere N. Samimi M, et al. Among authors: benlalam h. Cell Immunol. 2019 Oct;344:103961. doi: 10.1016/j.cellimm.2019.103961. Epub 2019 Aug 1. Cell Immunol. 2019. PMID: 31472938

8

Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.

Ollier J, Kervarrec T, Samimi M, Benlalam H, Aumont P, Vivien R, Touzé A, Labarrière N, Vié H, Clémenceau B. Ollier J, et al. Among authors: benlalam h. Cancer Immunol Immunother. 2018 Aug;67(8):1209-1219. doi: 10.1007/s00262-018-2176-2. Epub 2018 May 28. Cancer Immunol Immunother. 2018. PMID: 29808366 Free PMC article.

9

Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL.

Benlalam H, Jalil A, Hasmim M, Pang B, Tamouza R, Mitterrand M, Godet Y, Lamerant N, Robert C, Avril MF, Neefjes J, Tursz T, Mami-Chouaib F, Kieda C, Chouaib S. Benlalam H, et al. J Immunol. 2009 Mar 1;182(5):2654-64. doi: 10.4049/jimmunol.0800815. J Immunol. 2009. PMID: 19234159

10

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.

Ducoin K, Oger R, Bilonda Mutala L, Deleine C, Jouand N, Desfrançois J, Podevin J, Duchalais E, Cruard J, Benlalam H, Labarrière N, Bossard C, Jarry A, Gervois-Segain N. Ducoin K, et al. Among authors: benlalam h. Oncoimmunology. 2022 Mar 9;11(1):2046931. doi: 10.1080/2162402X.2022.2046931. eCollection 2022. Oncoimmunology. 2022. PMID: 35295095 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters